Zydus Lifesciences Limited announced the closure of its trading window in compliance with the Code of Insider Trading. The window will be shut from Thursday, January 1, 2026. It will remain closed until 48 hours after the declaration of the unaudited financial results for the quarter and nine months ending December 31, 2025. This closure applies to Directors, Designated Persons, and their immediate relatives concerning trading in the company's equity shares. The specific date for the Board meeting to approve these financial results will be communicated in due course.
